🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
1.370
-0.060 (-4.20%)
Nov 18, 2026, 4:00 PM EST - Market closed

Kalaris Therapeutics Statistics

Total Valuation

KLRS has a market cap or net worth of $32.61 million. The enterprise value is -$48.91 million.

Market Cap32.61M
Enterprise Value -48.91M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

KLRS has 23.80 million shares outstanding. The number of shares has increased by 41.55% in one year.

Current Share Class 23.80M
Shares Outstanding 23.80M
Shares Change (YoY) +41.55%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 6.02%
Owned by Institutions (%) 12.78%
Float 5.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.69
P/TBV Ratio 0.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.00, with a Debt / Equity ratio of 0.03.

Current Ratio 10.00
Quick Ratio 9.73
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -97.23% and return on invested capital (ROIC) is -63.53%.

Return on Equity (ROE) -97.23%
Return on Assets (ROA) -34.40%
Return on Invested Capital (ROIC) -63.53%
Return on Capital Employed (ROCE) -58.18%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$2.17M
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.72% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -74.72%
50-Day Moving Average 2.41
200-Day Moving Average 4.91
Relative Strength Index (RSI) 27.92
Average Volume (20 Days) 85,295

Short Selling Information

The latest short interest is 366,632, so 1.54% of the outstanding shares have been sold short.

Short Interest 366,632
Short Previous Month 306,400
Short % of Shares Out 1.54%
Short % of Float 6.22%
Short Ratio (days to cover) 4.58

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -46.83M
Pretax Income -43.40M
Net Income -43.40M
EBITDA -46.79M
EBIT -46.83M
Earnings Per Share (EPS) -$1.91
Full Income Statement

Balance Sheet

The company has $82.86 million in cash and $1.33 million in debt, with a net cash position of $81.52 million or $3.42 per share.

Cash & Cash Equivalents 82.86M
Total Debt 1.33M
Net Cash 81.52M
Net Cash Per Share $3.42
Equity (Book Value) 47.40M
Book Value Per Share 1.99
Working Capital 76.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.02 million and capital expenditures -$200,000, giving a free cash flow of -$41.22 million.

Operating Cash Flow -41.02M
Capital Expenditures -200,000
Depreciation & Amortization 40,000
Net Borrowing n/a
Free Cash Flow -41.22M
FCF Per Share -$1.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KLRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -41.55%
Shareholder Yield -41.55%
Earnings Yield -139.57%
FCF Yield -126.38%

Analyst Forecast

The average price target for KLRS is $16.33, which is 1,091.97% higher than the current price. The consensus rating is "Buy".

Price Target $16.33
Price Target Difference 1,091.97%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1